Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

Stopped early · Phase 2

Conditions studied: Diabetic Retinopathy, Diabetes Complications

In brief

To evaluate the effectiveness of study drug in improving visual acuity compared to laser treatment in the patients with diabetic macular edema

Key facts

Study ID

NCT00701181

Run by

Quark Pharmaceuticals

People needed

184

Starts

2008-06-01

Expected to finish

2011-01-01

Last updated by the study team

2012-10-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with Diabetes Mellitus (Type 1 or Type 2) Showing Diabetic Macular Edema in the Eye.

You may not qualify if…

• Proliferative Diabetic Retinopathy in the Study Eye.
• Subjects Receiving Concomitant Intravitreal Anti-VEGF Therapy.

Where it is running

• Pfizer Investigational Site — Meza, Arizona, United States
• Pfizer Investigational Site — Peoria, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Mountain View, California, United States
• Pfizer Investigational Site — Lakeland, Florida, United States
• Pfizer Investigational Site — Winter Haven, Florida, United States
• Pfizer Investigational Site — Augusta, Georgia, United States
• Pfizer Investigational Site — ‘Aiea, Hawaii, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — New Albany, Indiana, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Henderson, Nevada, United States
• Pfizer Investigational Site — Henderson, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Portsmouth, New Hampshire, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — High Point, North Carolina, United States
• Pfizer Investigational Site — Statesville, North Carolina, United States
• Pfizer Investigational Site — Winston-Salem, North Carolina, United States
• Pfizer Investigational Site — Rapid City, South Dakota, United States
• Pfizer Investigational Site — Mesa, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.